Biosimilar Avastin Is Launched In India

Cadila Pharmaceuticals Announces Entry

IndianPill
Cadila says it plans to launch “multiple biosimilar products this year for the Indian market.” • Source: Shutterstock

More from Biosimilars

More from Products